29 Einträge gefunden

1. Amplification of 8q21 in breast cancer is independent of MYC and associated with poor patient outcome.

   1. Choschzick, Matthias
   2. Lassen, Paula
   3. Lebeau, Annette
   4. Marx, Andreas
   5. Terracciano, Luigi
   6. Heilenkötter, Uwe
   7. Jänicke, Fritz

   2010 - Forschungsinformationssystem des UKE
2. Isolated limb perfusion with melphalan for the treatment of intractable primary cutaneous diffuse large B-cell lymphoma leg type.

   1. Kobold, Sebastian
   2. Kilic, Nerbil
   3. Luetkens, Tim
   4. Bokemeyer, Carsten
   5. Fiedler, Walter

   2010 - Forschungsinformationssystem des UKE
3. Catumaxomab--trifunctional anti-EpCAM antibody used to treat malignant ascites.

   1. Bokemeyer, Carsten

   2010 - Forschungsinformationssystem des UKE
4. Prognostic factors and treatment options in patients with leptomeningeal metastases of different primary tumors: a retrospective analysis.

   1. Oechsle, Karin
   2. Lange-Brock, Victoria
   3. Krüll, Andreas
   4. Bokemeyer, Carsten
   5. De Wit, Maike

   2010 - Forschungsinformationssystem des UKE
5. Expression and prognostic relevance of MAGE-C1/CT7 and MAGE-C2/CT10 in osteolytic lesions of patients with multiple myeloma.

   1. Pabst, Caroline
   2. Zustin, Jozef
   3. Jacobsen, Frank
   4. Luetkens, Tim
   5. Kröger, Nicolaus
   6. Schilling, Georgia
   7. Bokemeyer, Carsten

   2010 - Forschungsinformationssystem des UKE
6. Chromosome 8p deletions and 8q gains are associated with tumor progression and poor prognosis in prostate cancer.

   1. El Gammal, Alexander Tarek
   2. Brüchmann, Michael
   3. Zustin, Jozef
   4. Isbarn, Hendrik
   5. Hellwinkel, Olaf
   6. Köllermann, Jens
   7. Sauter, Guido

   2010 - Forschungsinformationssystem des UKE
7. Cucurbitacin B, a novel in vivo potentiator of gemcitabine with low toxicity in the treatment of pancreatic cancer.

   1. Iwanski, Gabriela B
   2. Lee, Dhong H
   3. En-Gal, Shlomit
   4. Doan, Ngan B
   5. Castor, Brandon
   6. Vogt, Marco
   7. Toh, Melvin

   2010 - Forschungsinformationssystem des UKE
8. Heterogenous high-level HER-2 amplification in a small subset of colorectal cancers.

   1. Marx, Andreas
   2. Burandt, Eike Christian
   3. Choschzick, Matthias
   4. Simon, Ronald
   5. Yekebas, Emre F.
   6. Kaifi, Jussuf
   7. Mirlacher, Martina

   2010 - Forschungsinformationssystem des UKE
9. Development and approval of the trifunctional antibody catumaxomab (anti-EpCAM x anti-CD3) as a targeted cancer immunotherapy.

   1. Seimetz, Diane
   2. Lindhofer, Horst
   3. Bokemeyer, Carsten

   2010 - Forschungsinformationssystem des UKE
10. Elevated pretreatment serum concentration of YKL-40-An independent prognostic biomarker for poor survival in patients with metastatic nonsmall cell lung cancer.

    1. Thoem, Ina
    2. Andritzky, Birte
    3. Schuch, Gunter
    4. Burkholder, Iris
    5. Edler, Lutz
    6. Johansen, Julia S
    7. Bokemeyer, Carsten

    2010 - Forschungsinformationssystem des UKE
11. Chemotherapie und systemische Therapie bei Lebermetastasen - Kolorektales Karzinom

    1. Folprecht, G
    2. Bokemeyer, Carsten

    2010 - Forschungsinformationssystem des UKE
12. Tgf-Beta superfamily receptors-targets for antiangiogenic therapy?

    1. Wellbrock, Jasmin
    2. Bokemeyer, Carsten
    3. Fiedler, Walter

    2010 - Forschungsinformationssystem des UKE - frei zugänglich
13. Low level HER2 overexpression is associated with rapid tumor cell proliferation and poor prognosis in prostate cancer.

    1. Minner, Sarah Jane Pauline
    2. Jessen, Birte
    3. Stiedenroth, Lars
    4. Burandt, Eike Christian
    5. Köllermann, Jens
    6. Mirlacher, Martina
    7. Erbersdobler, Andreas

    2010 - Forschungsinformationssystem des UKE
14. Autoantibodies against tumor-related antigens: incidence and biologic significance.

    1. Kobold, Sebastian
    2. Luetkens, Tim
    3. Cao, Yanran
    4. Bokemeyer, Carsten
    5. Atanackovic, Djordje

    2010 - Forschungsinformationssystem des UKE
15. Therapie von Hodentumoren: Stadienspezifisch und leitliniengerecht behandeln

    1. Honecker, Friedemann
    2. Souchon, R
    3. Krege, S
    4. Bokemeyer, Carsten

    2010 - Forschungsinformationssystem des UKE
16. Patterns of relapse after chemotherapy in patients with high-risk non-seminomatous germ cell tumor.

    1. Oechsle, Karin
    2. Lorch, Anja
    3. Honecker, Friedemann
    4. Kollmannsberger, Christian
    5. Hartmann, Jörg T
    6. Boehlke, Ina
    7. Beyer, Jörg

    2010 - Forschungsinformationssystem des UKE
17. Prognostic and diagnostic value of spontaneous tumor-related antibodies.

    1. Kobold, Sebastian
    2. Luetkens, Tim
    3. Cao, Yanran
    4. Bokemeyer, Carsten
    5. Atanackovic, Djordje

    2010 - Forschungsinformationssystem des UKE - frei zugänglich
18. High dose chemotherapy as salvage treatment for unresectable late relapse germ cell tumors.

    1. Lorch, Anja
    2. Rick, Oliver
    3. Wündisch, Thomas
    4. Hartmann, Jörg-Thomas
    5. Bokemeyer, Carsten
    6. Beyer, Jörg

    2010 - Forschungsinformationssystem des UKE
19. An optimized assay for the enumeration of antigen-specific memory B cells in different compartments of the human body.

    1. Cao, Yanran
    2. Gordic, Maja
    3. Kobold, Sebastian
    4. Lajmi, Nesrine
    5. Meyer, Sabrina
    6. Bartels, Katrin
    7. Hildebrandt, York

    2010 - Forschungsinformationssystem des UKE
20. Organprotektion in der Tumortherapie - mit Medikamenten vor unerwünschten Wirkungen schützen

    1. Oechsle, Karin
    2. Bokemeyer, Carsten

    2010 - Forschungsinformationssystem des UKE